CRP and melanoma: Conversely, I-CRP protects mice against 5-Fluorouracil-induced bone marrow myeloablation (Coronado-Cerda et al., 2016), while it increases the rate of oxaliplatin-induced immunogenic cell death in murine melanoma cells (Rodríguez-Salazar et al., 2017).